Ethical and legal implications of pharmacogenomics

被引：78
|
作者：
Rothstein, MA
Epps, PG
机构：
[1] Univ Louisville, Inst Bioeth Hlth Policy & Law, Sch Med, Louisville, KY 40202 USA
[2] Univ Houston, Hlth Law & Policy Inst, Ctr Law, Houston, TX 77204 USA
来源：
NATURE REVIEWS GENETICS | 2001年 / 2卷 / 03期
关键词：
D O I：
10.1038/35056075
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
Pharmacogenomics is the application of genomics technology to the discovery and development of drugs. A greater understanding of the way in which individuals with a particular genotype respond to a drug allows manufacturers to identify population subgroups that will benefit most from a particular drug. The increasing emphasis on pharmacogenomics is likely to raise ethical and legal questions regarding, among other things, the design of research studies, the construction of clinical trials and the pricing of drugs.
引用
收藏
页码：228 / 231
页数：4
相关论文
共 50 条
12345